AJP - Endo Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 279: E608-E613, 2000;
0193-1849/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hankard, R. G.
Right arrow Articles by Darmaun, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hankard, R. G.
Right arrow Articles by Darmaun, D.
Vol. 279, Issue 3, E608-E613, September 2000

Role of glucose in the regulation of glutamine metabolism in health and in type 1 insulin-dependent diabetes

Régis G. Hankard1,2, Morey W. Haymond1,3, and Dominique Darmaun1,4

1 Nemours Children's Clinic, Jacksonville, Florida 32207; 2 Centre d'Investigation Clinique, Hôpital Robert-Debré, Paris, France; 3 US Department of Agriculture Children's Nutrition Research Center, Baylor College of Medicine, Houston, Texas 77030; and 4 Unité 539, Institut National de La Santé et de la Recherche Médicale, Centre de Recherche en Nutrition Humaine, Hôpital Hotel-Dieu, 44093 Nantes, France

To determine the effect of glucose availability on glutamine metabolism, glutamine kinetics were assessed under conditions of hyperglycemia resulting from 1) intravenous infusion of 7.5% dextrose in healthy adults and 2) insulin deficiency in young adults with insulin-dependent diabetes mellitus (IDDM). Eight healthy adults and five young adults with IDDM were studied in the postabsorptive state by use of a primed continuous infusion of D-[U-14C]glucose, L-[5,5,5-2H3]leucine, and L-[3,4-13C]glutamine. Whether resulting from insulin deficiency or dextrose infusion, the rise in plasma glucose was associated with increased glucose turnover (23.5 ± 0.7 vs. 12.9 ± 0.3 µmol · kg-1 · min-1, P < 0.01 and 20.9 ± 2.5 vs. 12.8 ± 0.4 µmol · kg-1 · min-1, P = 0.03, in health and IDDM, respectively). In both cases, high blood glucose failed to alter glutamine appearance rate (Ra) into plasma [298 ± 9 vs. 312 ± 14 µmol · kg-1 · h-1, not significant (NS) and 309 ± 23 vs 296 ± 26 µmol · kg-1 · h-1, NS, in health and IDDM, respectively] and the estimated fraction of glutamine Ra arising from de novo synthesis (210 ± 7 vs. 217 ± 10 µmol · kg-1 · h-1, NS and 210 ± 16 vs. 207 ± 21 µmol · kg-1 · h-1, NS, in health and IDDM, respectively). When compared with the euglycemic day, the apparent contribution of glucose to glutamine carbon skeleton increased when high plasma glucose resulted from intravenous dextrose infusion in healthy volunteers (10 ± 0.8 vs. 4.8 ± 0.3%, P < 0.01) but failed to do so when hyperglycemia resulted from insulin deficiency in IDDM. We conclude that 1) the contribution of glucose to the estimated rate of glutamine de novo synthesis does not increase when elevation of plasma glucose results from insulin deficiency, and 2) the transfer of carbon from glucose to glutamine may depend on insulin availability.

leucine; isotope labeling; energy metabolism; substrate cycling; nutrition





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online